Lapatinib cas 231277-92-2 for Breast Cancer Treatment (jerryzhang001@chembj.com) - Nanjing Bangnuo Biotechnology Co., Ltd.

Lapatinib cas 231277-92-2 for Breast Cancer Treatment (jerryzhang001@chembj.com)

PRICE: 5 USD
Company:
Nanjing Bangnuo Biotechnology Co., Ltd.
Contact Person:
Jerry Zhang
Phone:
86-25-52198306


Product Description

Oral Safe and Super Pure 99% Lapatinib CAS 231277-92-2 for Breast Cancer Treatment

 

  1. Quick Detail: 

 

Name:Lapatinib

Purity : 99%

CAS : 231277-92-2

MF: C29H26ClFN4O4S

MW: 581.0575432

Grade: Oral pharmaceutical intermediate

Place of Origin:  China

Brand Name: NJBNSteroid

Usage :  Lapatinib is an orally active drug for breast cancer and other solid tumours. It is a dual tyrosine kinase inhibitor which interrupts the HER2 growth receptor pathway. It is used in combination therapy for HER2-positive breast cancer. It is used for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress HER2 (ErbB2).

 

Description:

Lapatinib is a breast cancer targeted therapy drug, it is a tyrosine kinase inhibitor, which can inhibit the human epidermal growth factor receptor -1 (ErbB1) and human epidermal growth factor receptor -2 (ErbB2) tyrosine kinase activity. It is unique because it can play a role in a variety of ways, so that the breast cancer cells can not receive the desired signal for the growth . The mechanism is inhibiting the ATP site of intracellular EGFR(ErbB-1) and HER2 (ErbB-2) to prevent phosphorylation and activation of tumor cells, blocking down signal by EGFR (ErbB-1) and homogenous HER2 (ErbB-1) and its heterodimer.


Other products

Join Free